Sundarlal Pharma Distributors Private Limited - Company Profile

It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 2018.
2018 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Sundarlal Pharma Distributors Private Limited

Sundarlal Pharma Distributors Private Limited, a active private limited company, was established on 01 October 2018 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U51909MH2018PTC315127. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹1.00 Cr.

It upholds a compliant status. Employing 1 professional, Its leadership includes Amit Mangilal Bishnoi (Director), Vikramaditya Harishchandra Ambre (Director), Gaurav Kumar (Director). Past directors included Akshay Jain, Abhitesh Kumar, Arun Sadhanandham. It holds no open charges and ₹7.00 Cr settled loans. Its latest AGM occurred on 16 September 2025, with the balance sheet filed on 31 March 2025. It is based at 1238, Floor-Loft, Kishor Bhai Chawl, Tatya Tope Marg, Joglekarwadi, Son Fish Mkt, Sion (E), Mumbai, Mumbai, Maharashtra, 400022.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51909MH2018PTC315127

  • Registration Number

    315127

  • Incorporation Date

    01 October 2018

  • Authorized Capital

    ₹1.00 Cr

  • Paid-Up Capital

    ₹1.00 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 Cr
  • Paid Up Capital ₹ 1.00 Cr
  • Company Age 7 Year, 4 Months
  • Last Filing with ROC 31 Mar 2025
  • Satisfied Charges ₹ 7.00 Cr
  • Revenue Growth **** -34.68%
  • Profit Growth **** -113.70%
  • Ebitda **** -133.55%
  • Net Worth -12.46%
  • Total Assets -29.67%
Company report

Sundarlal Pharma Distributors Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Sundarlal Pharma Distributors Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Sundarlal Pharma Distributors Private Limited?
Current Directors
Name Designation Appointment Date Status
Amit Mangilal Bishnoi Director 26 Feb 2024 Current
Vikramaditya Harishchandra Ambre Director 01 Oct 2018 Current
Gaurav Kumar Director 30 Sep 2022 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 26 Feb 2024 Past
Pramod Abcsdd Director 30 Sep 2022 Past
Pramod Abcsdd Additional Director 24 Dec 2019 Past
Pramod Abcsdd Director 29 Dec 2020 Past
Pramod Abcsdd Director 16 Mar 2020 Past
Pramod Abcsdd Additional Director 29 Sep 2024 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sundarlal Pharma Distributors.

Sundarlal Pharma Distributors Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 34.68% decrease. The company also saw a substantial fall in profitability, with a 113.7% decrease in profit. The company's net worth observed a substantial decline by a decrease of 12.46%.

Sundarlal Pharma Distributors revenue growth over time
Sundarlal Pharma Distributors profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -34.68%
*******
*******
*******
*******
Revenue from Operations
*******
 -35.11%
*******
*******
*******
*******
Total Assets
*******
 -29.67%
*******
*******
*******
*******
Profit or Loss
*******
 -113.70%
*******
*******
*******
*******
Net Worth
*******
 -12.46%
*******
*******
*******
*******
EBITDA
*******
 -133.55%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sundarlal Pharma Distributors?

In 2023, Sundarlal Pharma Distributors had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹70,000,000.00

Charges Breakdown by Lending Institutions
  • Others : 7.00 Cr
Latest Charge Details
Date Lender Amount Status
18 Sep 2020 Others ₹7.00 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Sundarlal Pharma Distributors?

Sundarlal Pharma Distributors has a workforce of 1 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sundarlal Pharma Distributors, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sundarlal Pharma Distributors's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sundarlal Pharma Distributors
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Sundarlal Pharma Distributors Private Limited last Annual general meeting of members was held on 16 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Sundarlal Pharma Distributors Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.

  • Director Appointment

    The activity Amit Mangilal Bishnoi was appointed as a Director was appointed as a Director on 26 Feb 2024 & has been associated with this company since 2 years . was completed.

  • Charges

    Progress on A charge registered on 18 Sep 2020 via Charge ID 100377105 with Others was fully satisfied on 12 May 2023. was documented.

  • Director Appointment

    Progress on Gaurav Kumar was appointed as a Director was appointed as a Director on 30 Sep 2022 & has been associated with this company since 3 years 4 months . was documented.

  • Charges

    Progress on A charge with Others amounted to Rs. 7.00 Cr with Charge ID 100377105 was registered on 18 Sep 2020. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Sundarlal Pharma Distributors Private Limited?

The CIN of Sundarlal Pharma Distributors Private Limited is U51909MH2018PTC315127.

Where is Sundarlal Pharma Distributors Private Limited headquartered?

Sundarlal Pharma Distributors Private Limited is headquartered at 1238, Floor-Loft, Kishor Bhai Chawl, Tatya Tope Marg, Joglekarwadi, Son Fish Mkt, Sion (E), Mumbai, Mumbai, Maharashtra, 400022.

When was Sundarlal Pharma Distributors Private Limited incorporated?

Sundarlal Pharma Distributors Private Limited was incorporated on 01 October 2018.

Who are the current directors of Sundarlal Pharma Distributors Private Limited?

The current directors of Sundarlal Pharma Distributors Private Limited are

What is the primary industry of Sundarlal Pharma Distributors Private Limited?

The primary industry of Sundarlal Pharma Distributors Private Limited is Trade.

Is Sundarlal Pharma Distributors Private Limited a listed company?

Sundarlal Pharma Distributors Private Limited is unlisted.

What is the capital structure of Sundarlal Pharma Distributors Private Limited?

The authorized capital of Sundarlal Pharma Distributors Private Limited is ₹1.00 Cr, and the paid-up capital is ₹1.00 Cr.

What is the compliance status of Sundarlal Pharma Distributors Private Limited?

The compliance status of Sundarlal Pharma Distributors Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available